Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
460 participants
OBSERVATIONAL
2018-12-13
2026-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of General Anesthesia on Pharmacokinetics of Oxycodone in Pediatric
NCT03054831
Pharmacogenetics of Ketamine in Children
NCT05796232
Morphine or Ketamine for Analgesia
NCT06835504
Morphine PK Subgroup Analysis
NCT01322191
The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years
NCT01363076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drug of Interest
Individuals receiving anesthetics or analgesics per standard of care
Ketorolac Tromethamine
IV ketorolac will be given per standard of care, not prescribed for this study
Hydromorphone
IV Hydromorphone will be given per standard of care, not prescribed for this study
Ketamine
IV Ketamine will be given per standard of care, not prescribed for this study
Oxycodone
PO Oxycodone(solution or tablet) will be given per standard of care, not prescribed for this study
Morphine
IV Morphine will be given per standard of care, not prescribed for this study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketorolac Tromethamine
IV ketorolac will be given per standard of care, not prescribed for this study
Hydromorphone
IV Hydromorphone will be given per standard of care, not prescribed for this study
Ketamine
IV Ketamine will be given per standard of care, not prescribed for this study
Oxycodone
PO Oxycodone(solution or tablet) will be given per standard of care, not prescribed for this study
Morphine
IV Morphine will be given per standard of care, not prescribed for this study
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Parent and/or participant (if applicable) is able to understand the consent process and provides informed consent and HIPAA Authorization (if applicable)
3. Participant provides assent as required by the institutional review board (IRB) or research ethics board (REB)
4. Receiving one or more drugs of interest (DOI) per local standard of care
Exclusion Criteria
2. Extracorporeal life support (i.e., ECMO, dialysis, ventricular assist device)
3. Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study
0 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Emmes Company, LLC
INDUSTRY
Chi Dang Hornik
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chi Dang Hornik
Associate Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chi Hornik, PharmD
Role: PRINCIPAL_INVESTIGATOR
Duke Clinical Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lucile Packard Children's Hospital
Stanford, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Alfred I. DuPont Hospital for Children
Wilmington, Delaware, United States
Ann and Robert H. Lurie Childrens Hospital of Chicago
Chicago, Illinois, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
Duke University Medical Center
Durham, North Carolina, United States
Oregon Health and Science University
Portland, Oregon, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Dell Children's Medical Center of Texas
Austin, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
The Hospital for Sick Children
Toronto, Ontario, Canada
Hospital Sainte-Justine
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00088893
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.